Stake Announced Sponsor buyer

Stake in Anagram Therapeutics

Announced 11 May 2026

Advisers

Target
Anagram Therapeutics
Sponsor
Blackstone Life Sciences
Target based in
United States
Buyer based in
United States
Structure
Minority stake
Amount raised
US$250m
Sector
Biotech
Tags
Biotech, Drug Development, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.